You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

What's New in Guidelines & Advice

All documents recently added to the Guidelines & Advice area within the last 6 months are available here, as well as any updated documents.

Systemic Treatments for Unresectable and Metastatic Cutaneous Melanoma

Document Status: Current

ID: GL 8-12

New

Jan 2026

Evidence from Primary Studies and Systematic Reviews for June to December 2024

Document Status: Current

ID: PET 2024-2

New

Jan 2026

High-Risk Benign Breast Lesions Recommendations Report

Document Status: Current

Version: 1

Nov 2025

An Endorsement of the 2025 Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the EOTTD, ESGO, GCIG, ISSTD

Document Status: Current

ID: GL END 4-19

Nov 2025

The Use of Indoor Tanning Devices and the Risk of Developing Cutaneous Malignant Melanoma: A Systematic Review and Clinical Practice Guideline

Document Status: Current

ID: 8-8

Version: 2

Sep 2025

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Document Status: Current

ID: 7-13

Version: 2

Sep 2025

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Document Status: Current

Version: 2

Sep 2025